Osiris Therapeutics, Inc (OSIR)
7015 Albert Einstein Drive
Columbia, MD 21046
Osiris Therapeutics, Inc. is a leading stem cell company focused on developing and marketing products to treat medical conditions in the inflammatory, autoimmune, orthopedic and cardiovascular areas. Osiris' stem cell products have significant therapeutic potential because of their ability to regulate inflammation, promote tissue regeneration and prevent pathological scar formation.
C. Randal Mills, Ph.D., President and Chief Executive Officer
Philip R. Jacoby, Jr., Chief Financial Officer and Corporate Secretary
Michelle LeRoux Williams, Ph.D., Chief Scientific Officer
Lode Debrabandere, Ph.D., Senior Vice President, Therapeutics
Stephen W. Potter, Senior Vice President of Operations and Corporate Development
Douglas Jacobstein, M.D., Senior Director, Medical Affairs
Christopher R. Alder, J.D., Chief Intellectual Property Counsel
Important Company Highlights:
Prochymal is being evaluated in Phase 3 clinical trials for several indications, including acute graft versus host disease (GvHD) and also Crohn's disease, and is the only stem cell therapeutic currently designated by the FDA as both an Orphan Drug and Fast Track product.
Prochymal is also being developed for the repair of heart tissue following a heart attack, the protection of pancreatic islet cells in patients with type 1 diabetes, and the repair of lung tissue in patients with pulmonary disease.
Osiris has partnered with Genzyme Corporation to develop Prochymal as a medical countermeasure to nuclear terrorism and other radiological emergencies.
Chondrogen is currently being evaluated in clinical trials for the treatment of osteoarthritis in the knee. Enrollment for this trial has been completed.
44 W Lancaster Ave
Ardmore, PA 19003
32,790,019 as of Nov 4, 2010
90,000,000 as of Sept 30, 2010
All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.
Also, keep in mind that moderators may or may not have a position in said stock. Being a moderator isn't a sign of endorsement.
Please keep your posts on topic because your message(s) will probably be deleted when:
* Posting content that's off-topic to the subject of this board;
* Posting statements that don't add value to the discussion; or
* When you violate any other posting term of the iHub User Agreement: http://investorshub.advfn.com/boards/complex_terms.asp